1. Home
  2. LICN vs TVGN Comparison

LICN vs TVGN Comparison

Compare LICN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

HOLD

Current Price

$1.23

Market Cap

20.9M

Sector

N/A

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$6.89

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
TVGN
Founded
2004
2020
Country
China
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
21.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LICN
TVGN
Price
$1.23
$6.89
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
45.9K
6.7K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.14
52 Week High
$9.49
$12.03

Technical Indicators

Market Signals
Indicator
LICN
TVGN
Relative Strength Index (RSI) 44.48 52.09
Support Level $1.03 $6.22
Resistance Level $1.40 $7.42
Average True Range (ATR) 0.08 0.37
MACD 0.01 0.02
Stochastic Oscillator 16.74 67.29

Price Performance

Historical Comparison
LICN
TVGN

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational, and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and the sales of financial and taxation training software.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: